Last checked at 2 Mar 2021 07:00
REACH - non-regulatory announcement
2 March 2021
Tern Plc
("Tern" or the "Company")
Portfolio News
Tern Plc (AIM:TERN), the investment company specialising in the Internet of Things ("IoT"), is pleased to provide an update on the recent activities of a number of its portfolio companies), being Device Authority Limited ("Device Authority"), Talking Medicines Limited ("Talking Medicines") and Wyld Networks Limited ("Wyld Networks"):
· Device Authority successfully concluded its two day, sponsor funded, 'Virtual IoT Security Summit' last week, with expert speakers and strategic partners from some of the largest global players in the cyber identity and access management ("IAM") sector. The event attracted over 2,000 registrants, with over 1,400 delegates attending live topical sessions on solving the complex issues of IoT security. Support was received from Device Authority's strategic partners and industry leaders including Microsoft, BSI, EPS Global, Entrust, Ordr, Venafi and Imagination Technologies. The various presentations from the webinar can be viewed on-demand at:
https://www.brighttalk.com/summit/4892-virtual-iot-security-summit/
· Talking Medicines has been named on Healthcare UK's "First 100" list, published by the Department of International Trade, recognising the UK's leading digital health innovators.
· Wyld Networks has entered into a partnership with Fujitsu through the Fujitsu Ecosystem Platform to provide a further route to market for its products.
Commenting Al Sisto, CEO of Tern, said:
"I am pleased to see that the recent momentum with our portfolio companies is continuing. All have had a good start to 2021 and have promising pipelines of business.
"Device Authority's IoT summit last week, funded by its partner sponsors, was a particular milestone for the company, demonstrating the depth of their relationships and the important position their KeyScaler product has in the IoT. I wholly endorse one speaker from a global software company who commented that KeyScaler is 'the glue that holds the IoT together'.
"I would also like to congratulate Talking Medicines on being selected as part of Healthcare UK's 'Fast 100'. This recognises Talking Medicines' innovation and their commitment to global expansion.
"I look forward to providing further regular updates on the progress of our portfolio companies in due course."
Further information on Talking Medicines and the First 100
Talking Medicines has been named on Heathcare UK's "First 100" list published by the Department for International Trade. The "First 100" companies were selected after a rigorous process based on criteria including how committed they were to export and international expansion, the global uniqueness of their innovation, their track-record of working collaboratively with Healthcare UK, their responsiveness, and how well they represent the UK journey and direction in digital health, particularly with the NHS. The Department for International Trade have stated the list will be updated twice a year.
The First 100 campaign is backed by Healthcare UK, European Connected Health Alliance (ECHA), Association of British HealthTech Industries (ABHI), Scottish Development International, Innovate UK, HIMSS and the National Association of Primary Care (NAPC).
Commenting, Hassan Chaudhury, digital health specialist, Healthcare UK, said: "The First 100 articulates the exportable strengths that the UK has in health tech and showcases those that stand out for being tried and tested and most importantly, making a difference across one of the most complex health systems in the world, during its most challenging time."
Enquiries
Tern Plc Al Sisto (CEO) Sarah Payne (CFO) | via IFC Advisory |
Allenby Capital Limited (Nominated Adviser and Broker) David Worlidge / Alex Brearley (Corporate Finance) Matt Butlin / Kelly Gardiner (Sales and Corporate Broking) |
Tel: 0203 328 5656 |
IFC Advisory (Financial PR and IR) Tim Metcalfe Graham Herring Florence Chandler |
Tel: 0203 934 6630 tern@investor-focus.co.uk |
About Reach announcements
This is a Reach announcement. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.